"Immediate and vast market traction is almost unheard of in the beauty sector," said Dr. Hans Keirstead, Aivita's chief executive officer. "But the reasons for our successful launch in Japan are simple: the product works extremely well, and 100% of the proceeds are used to support the treatment of cancer."
Root of Skin MD is Aivita's proprietary consumer skincare line for skin rejuvenation, made possible through the same proprietary knowledge and expertise used to develop its cutting-edge cell therapies. The all-new actives complex SourceCode Technology contains the complete set of factors and supporting biological components present in young, healthy skin.
In addition to its Japanese market expansion, Aivita has also recently executed a partnership with the global multichannel marketing company Guthy-Renker to boost promotion of its products in the US and worldwide in 2020.
Aivita uses 100% of proceeds from the sale of its Root of Skin skincare product line to support the treatment of women with ovarian cancer.